Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD)

Histopathology

Volumn 53, Issue 5, 2008, Pages 513-524

  Chadburn, A ^a,b   Hyjek, E M ^a   Tam, W ^a   Liu, Y ^a   Rengifo, T ^a   Cesarman, E ^a   Knowles, D M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

HHV 8; HIV; KSHV; MCD; PRDM1 BLIMP1

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; B-LYMPHOCYTES; CELL DIFFERENTIATION; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LYMPHOMA, PRIMARY EFFUSION; MALE; MIDDLE AGED;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

EID: 54949105419     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03144.x     Document Type: Article

References (50)

1. Oksenhendler E, Boulanger E, Galicier L et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002 99 61 67.
2. Oksenhendler E, Duarte M, Soulier J et al. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS 1996 10 61 67.
3. Soulier J, Grollet L, Oksenhendler E et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995 86 1275 1280.
4. Chang Y, Cesarman E, Pessin MS et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994 266 1865 1869.
5. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body cavity-based-lymphomas. N. Engl. J. Med. 1995 332 1186 1191.
6. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma lesions from persons with and without HIV infection. N. Engl. J. Med. 1995 332 1181 1185.
7. Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am. J. Surg. Pathol. 2004 28 1401 1416.
8. Nador RG, Cesarman E, Chadburn A et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpesvirus. Blood 1996 88 645 656.
9. Dupin N, Diss TL, Kellam P et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000 95 1406 1412.
10. Mesri EA, Cesarman E, Arvanitakis L et al. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J. Exp. Med. 1996 183 2385 2390.
11. Boshoff C, Schulz TF, Kennedy MM et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1995 1 1274 1278.
12. Dupin N, Fisher C, Kellam P et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl Acad. Sci. USA 1999 96 4546 4551.
13. Parravicini C, Corbellino M, Paulli M et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am. J. Pathol. 1997 151 1517 1522.
14. Carbone A, Gloghini A, Cozzi MR et al. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis. Br. J. Haematol. 2000 111 247 257.
15. Matolcsy A, Nador RG, Cesarman E, Knowles DM. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am. J. Pathol. 1998 153 1609 1614.
16. Klein U, Gloghini A, Gaidano G et al. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 2003 101 4115 4121.
17. Hamoudi R, Diss TC, Oksenhendler E et al. Distinct cellular origins of primary effusion lymphoma with and without EBV infection. Leuk. Res. 2004 28 333 338.
18. Du MQ, Liu H, Diss TC et al. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 2001 97 2130 2136.
19. Li CF, Ye H, Liu H, Du MQ, Chuang SS. Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative immunocompetent patient with plasmablastic variant of multicentric Castleman disease (plasmablastic microlymphoma). Am. J. Surg. Pathol. 2006 30 123 127.
20. Pasqualucci L, Compagno M, Houldsworth J et al. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J. Exp. Med. 2006 203 311 317.
21. Tam W, Gomez M, Chadburn A, Lee JW, Chan WC, Knowles DM. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood 2006 107 4090 4100.
22. Shaffer AL, Lin KI, Kuo TC et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002 17 51 62.
23. Turner CA, Mack DH, Davis MM. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin- secreting cells. Cell 1994 77 297 306.
24. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat. Rev. Immunol. 2005 5 230 242.
25. Lin Y, Wong K, Calame K. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 1997 276 596 599.
26. Lin KI, Angelin-Duclos C, Kuo TC, Calame K. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol. Cell. Biol. 2002 22 4771 4780.
27. Shapiro-Shelef M, Lin KI, McHeyzer-Williams LJ, Liao J, McHeyzer-Williams MG, Calame K. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 2003 19 607 620.
28. Jenner RG, Maillard K, Cattini N et al. Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc. Natl Acad. Sci. USA 2003 100 10399 10404.
29. Frizzera G. Atypical lymphoproliferative disorders. In Knowles DM ed. Neoplastic Hematopathology. Philadelphia : Lippincott Williams and Wilkins, 2001 569 622.
30. Chadburn A, Metroka C, Mouradian J. Progressive lymph node histology and its prognostic value in patients with acquired immunodeficiency syndrome and AIDS-related complex. Hum. Pathol. 1989 20 579 587.
31. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996 274 1739 1744.
32. Yoshizaki K, Matsuda T, Nishimoto N et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989 74 1360 1367.
33. Oksenhendler E, Carcelain G, Aoki Y et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood 2000 96 2069 2073.
34. Shapiro-Shelef M, Lin KI, Savitsky D, Liao J, Calame K. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J. Exp. Med. 2005 202 1471 1476.
35. Shapiro-Shelef M, Calame K. Plasma cell differentiation and multiple myeloma. Curr. Opin. Immunol. 2004 16 226 234.
36. Garcia JF, Roncador G, Garcia JF et al. PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma. Haematologica 2006 91 467 474.
37. Cattoretti G, Angelin-Duclos C, Shaknovich R, Zhou H, Wang D, Alobeid B. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage. J. Pathol. 2005 206 76 86.
38. Brighenti A, Andrulis M, Geissinger E, Roth S, Muller-Hermelink HK, Rudiger T. Extrafollicular proliferation of B cells in the absence of follicular hyperplasia: a distinct reaction pattern in lymph nodes correlated with primary or recall type responses. Histopathology 2005 47 90 100.
39. MacLennan IC, Toellner KM, Cunningham AF et al. Extrafollicular antibody responses. Immunol. Rev. 2003 194 8 18.
40. Klein U, Goossens T, Fischer M et al. Somatic hypermutation in normal and transformed human B cells. Immunol. Rev. 1998 162 261 280.
41. Arguello M, Sgarbanti M, Hernandez E et al. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. Oncogene 2003 22 964 973.
42. Fan W, Bubman D, Chadburn A, Harrington WJ Jr., Cesarman E, Knowles DM. Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. J. Virol. 2005 79 1244 1251.
43. Mancao C, Altmann M, Jungnickel B, Hammerschmidt W. Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus. Blood 2005 106 4339 4344.
44. Huggins J, Pellegrin T, Felgar RE et al. CpG DNA activation and plasma-cell differentiation of CD27-naive human B cells. Blood 2007 109 1611 1619.
45. Nagumo H, Agematsu K, Kobayashi N et al. The different process of class switching and somatic hypermutation; a novel analysis by CD27(-) naive B cells. Blood 2002 99 567 575.
46. Wei C, Anolik J, Cappione A et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J. Immunol. 2007 178 6624 6633.
47. Jung J, Choe J, Li L, Choi YS. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur. J. Immunol. 2000 30 2437 2443.
48. Dong HY, Shahsafaei A, Dorfman DM. CD148 and CD27 are expressed in B cell lymphomas derived from both memory and naive B cells. Leuk. Lymphoma 2002 43 1855 1858.
49. Marafioti T, Jones M, Facchetti F et al. Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood 2003 102 2868 2876.
50. Pasqualucci L, Migliazza A, Fracchiolla N et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl Acad. Sci. USA 1998 95 11816 11821.